- Fecal Incontinence
|Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
Camacho-Soto A1, Gross A1, Searles Nielsen S1, Dey N2, Racette BA3. Parkinsonism Relat Disord. 2018 Feb 9. pii: S1353-8020(18)30044-0. doi: 10.1016/j.parkreldis.2018.02.008. [Epub ahead of print]
1 Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
2 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
3 Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: firstname.lastname@example.org.
INTRODUCTION: Gastrointestinal (GI) dysfunction precedes the motor symptoms of Parkinson's disease (PD) by several years. PD patients have abnormal aggregation of intestinal α-synuclein, the accumulation of which may be promoted by inflammation. The relationship between intestinal α-synuclein aggregates and central nervous system neuropathology is unknown. Recently, we observed a possible inverse association between inflammatory bowel disease (IBD) and PD as part of a predictive model of PD. Therefore, the objective of this study was to examine the relationship between PD risk and IBD and IBD-associated conditions and treatment.
METHODS: Using a case-control design, we identified 89,790 newly diagnosed PD cases and 118,095 population-based controls >65 years of age using comprehensive Medicare data from 2004-2009 including detailed claims data. We classified IBD using International Classification of Diseases version 9 (ICD-9) diagnosis codes. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between PD and IBD. Covariates included age, sex, race/ethnicity, smoking, Elixhauser comorbidities, and health care use.
RESULTS: PD was inversely associated with IBD overall (OR = 0.85, 95% CI 0.80-0.91) and with both Crohn's disease (OR = 0.83, 95% CI 0.74-0.93) and ulcerative colitis (OR = 0.88, 95% CI 0.82-0.96). Among beneficiaries with ≥2 ICD-9 codes for IBD, there was an inverse dose-response association between number of IBD ICD-9 codes, as a potential proxy for IBD severity, and PD (p-for-trend = 0.006).
CONCLUSION: IBD is associated with a lower risk of developing PD.